EBV-Specific Immune Response: Early Research and Personal Reminiscences

Area of Science:

• Virology
• Immunology
• Oncology

Background:

• Early Epstein-Barr virus (EBV) research focused on serological responses.
• Antibody patterns to EBV antigens (MA, EA, EBNA) were key to linking EBV with infectious mononucleosis (IM), Burkitt's lymphoma (BL), and nasopharyngeal carcinoma (NPC).

Observation:

• The lymphocytosis in acute IM was noted to be T cell-dominated.
• T cells from acute IM patients underwent apoptosis shortly after blood separation.
• EBV-infected cultures from immune individuals showed regression around 10 days post-seeding, indicating a memory response.

Findings:

• Initial studies debated whether T cell responses controlling EBV were non-specific or HLA non-restricted.
• The regression of EBV-infected cells provided the first evidence of a specific memory T cell response.
• Initially, CD8(+) T cells were implicated, with later research suggesting a role for CD4(+) T cells.

Implications:

• Understanding EBV's serological and cellular immune responses is crucial for disease association studies.
• The discovery of a specific memory T cell response highlights the adaptive immune system's role in controlling latent EBV infection.
• This historical review provides insights into the early development of EBV immunology and its clinical relevance.